The burden of skin disease: Quality of life, economic aspects and social issues

Clinical Medicine, Journal of the Royal College of Physicians of London

Volumn 9, Issue 6, 2009, Pages 592-594

  Finlay, Andrew Y ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL DECISION MAKING; CLINICAL RESEARCH; COMPENSATION; COST EFFECTIVENESS ANALYSIS; DISABILITY; DISEASE SEVERITY; ECONOMIC ASPECT; HEALTH CARE COST; HUMAN; LASER SURGERY; OCCUPATIONAL DISEASE; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT MONITORING; PSORIASIS; QUALITY OF LIFE; REVIEW; SKIN DISEASE; SKIN INFLAMMATION; SOCIAL ASPECT; SYSTEMIC THERAPY;

EID: 71849116117     PISSN: 14702118     EISSN: 14734893     Source Type: Journal    
DOI: 10.7861/clinmedicine.9-6-592     Document Type: Review

References (21)

1. Sauer GC. A guide to the evaluation of permanent impairment of the skin. Arch Dermatol 1968;97:566-569
2. Robinson HM. Measurement of impairment and disability in dermatology. Arch Dermatol 1973;108:207-209
3. Baughman RD, Sobel R. Psoriasis - a measure of severity. Arch Dermatol 1970;101:390-395
4. Jowett S, Ryan T. Skin disease and handicap: an analysis of the impact of skin conditions. Soc Sci Med 1985;20:425-429 (Pubitemid 15235778)
5. Finlay AY, Kelly SE. Psoriasis - an index of disability. Clin Exper Dermatol 1987;12:8-11.
6. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI): a simple practical measure for routine clinical use. Clin Exp Dermatol 1994;19:210-216
7. Hongbo Y, Thomas CL, Harrison MA, Salek MS, Finlay AY. Translating the science of quality of life into practice: what do Dermatology Life Quality Index scores mean? J Invest Dermatol 2005;125:659-664
8. Finlay AY. Current severe psoriasis and the Rule of Tens. Br J Dermatol 2005;152:861-867
9. Smith CH, Anstey AV, Barker JN et al. British Association of Dermatologists guidelines for the use of biological interventions in psoriasis 2005. Br J Dermatol 2005;153:486-489
10. Basra MKA, Fenech R, Gatt RM, Salek MS, Finlay AY. The DLQI 1994-2007: a comprehensive review of validation data and clinical results. Br J Dermatol 2008;159:997-1035.
11. Chren M-M, Lasek RJ, Quinn LM, Mostow EN, Zyzanski SJ. Skindex, a Quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J Invest Dermatol 1996;107:707-713
12. Rapp SR, Feldman SR, Exum ML, Fleischer AB, Reboussin DM. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 1999;41:401-407
13. All Party Parliamentary Group on Skin. Report on the enquiry into the impact of skin disease on people's lives. London: All Party Parliamentary Group on Skin, 2003.
14. Lewis-Jones MS, Finlay AY. The Children's Dermatology Life Quality Index (CDLQI): initial validation and practical use. Br J Dermatol 1995;132:942-949
15. Basra MKA, Finlay AY. The family impact of skin disease: the Greater Patient concept. Br J Dermatol 2007;156:929-937
16. Nijsten T, Meads DM, de Korte J et al. Cross-cultural inequivalence of dermatology-specific health-related quality of life instruments in psoriasis patients. J Invest Dermatol 2007;127:2315-2322 (Pubitemid 47619752)
17. DeLong LK, Culler SD, Saini SS, Beck LA, Chen SC. Annual direct and indirect health care costs of chronic idiopathic urticaria. Arch Dermatol 2008;144:35-39
18. Bickers DR, Lim HW, Margolis D et al. The burden of skin diseases: 2004. A joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology. J Am Acad Dermatol 2006;55:490-500.
19. Schmitt J, Meurer M, Klon M, Frick KD. Assessment of health state utilities of controlled and uncontrolled psoriasis and atopic eczema: a population-based study. Br J Dermatol 2008;158:351-359
20. Mancini AJ, Kaulback K, Chamlin SL. The socioeconomic impact of atopic dermatitis in the United States: a systematic review. Pediatr Dermatol 2008;25:1-6. (Pubitemid 351315442)
21. Inglese MJ, Fleischer AB Jr, Feldman SR, Balkrishnan R. The pharmacoeconomics of acne treatment: where are we heading? J Dermatolog Treat 2008;19:27-37. (Pubitemid 351252716)